U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07608835) titled 'IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy' on Feb. 11.
Brief Summary: Immunotherapy has helped improve the prognosis of metastatic lung cancer. However, only about 40% of patients respond to conventional immunotherapy with anti-PD(L)-1 agents. This research aims to identify biomarkers of response to immunotherapy at the tumor level and to characterize new therapeutic targets
Study Start Date: Feb. 12
Study Type: INTERVENTIONAL
Condition:
Non-small Cell Lung Cancer
Intervention:
PROCEDURE: prospective collection of blood and tumor samples
The procedure under study is based on...